MedTrace Logo

A Study of V132 in Healthy Older Participants (V132-001)

NCT07712575 · Status: NOT_YET_RECRUITING · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 280

Last updated 2026-07-17

No results posted yet for this study

Summary

The goal of this study is to learn about the safety and immune response to the V132 vaccine in healthy older adults.

Conditions

  • Healthy

Interventions

BIOLOGICAL

V132 Formulation 1

Experimental

BIOLOGICAL

V132 Formulation 2

Experimental

BIOLOGICAL

V132 Formulation 3

Experimental

BIOLOGICAL

PREVNAR 20™

Active Comparator

BIOLOGICAL

CAPVAXIVE™

Active Comparator

Sponsors & Collaborators

Principal Investigators

  • Medical Director · Merck Sharp & Dohme LLC

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
DOUBLE
Model
SEQUENTIAL

Eligibility

Min Age
50 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-08-17
Primary Completion
2028-06-21
Completion
2028-06-21
FDA Drug
Yes

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07712575 on ClinicalTrials.gov